Opinion
Video
Navigating Access Barriers: Resources to Support New Treatment Access
Panelists discuss how leveraging resources such as patient assistance programs, insurance navigators, clinical trial databases, advocacy groups, and oncology support services can help overcome access barriers, ensuring that NMIBC patients receive timely access to novel treatments like nadofaragene firadenovec and pembrolizumab.
Physician Summary: Navigating Access Barriers – Resources to Support New Treatment Access
Overcoming access barriers to new treatments for non-muscle invasive bladder cancer (NMIBC) involves leveraging available resources to support both patients and health care providers. Key resources to help navigate these challenges include:
- Patient Assistance Programs: Many pharmaceutical companies offer programs to help cover the cost of new therapies. These programs can provide financial assistance, co-pay support, and other resources to help patients access treatments like nadofaragene firadenovec and pembrolizumab.
- Insurance Navigators: Professional navigators or patient advocates can assist in working through insurance complexities. They help ensure the appropriate documentation is submitted for insurance approval, increasing the likelihood of reimbursement for newer therapies.
- Clinical Trial Databases: For patients who may not yet have access to approved treatments, clinical trials can provide an alternative. Databases like ClinicalTrials.gov can help identify ongoing trials that may offer investigational treatments with potential access to cutting-edge therapies.
- Regulatory and Advocacy Groups: Organizations such as the American Cancer Society or Bladder Cancer Advocacy Network can provide information on regulatory changes, help advocate for policy improvements, and guide patients through the approval process for new treatments.
- Oncology Support Services: Multidisciplinary teams, including pharmacists and social workers, can offer guidance on accessing new therapies. These teams often help streamline the treatment process, from obtaining medications to managing adverse effects.
By utilizing these resources, physicians can better navigate the complexities of treatment access, ensuring their patients receive the latest and most effective therapies for NMIBC.
